10 years of success achieved by eribulin while treating HER2-negative mBC: from randomized studies to routine practice

The article reviews studies evaluating the efficacy and safety of eribulin chemotherapy in patients with HER2-negative advanced breast cancer. It analyzes the results derived from large randomized studies, highlights the main advantages peculiar to eribulin, and describes the key mechanisms of the a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: I. V. Kolyadina
Formato: Artigo
Idioma:Russo
Publicado em: ABV-press 2021-10-01
Colecção:Opuholi Ženskoj Reproduktivnoj Sistemy
Assuntos:
metastatic breast cancer
late-line chemotherapy
early-line chemotherapy
eribulin
visceral metastases
brain metastases
chemotherapy in elderly patients
russian experience of using eribulin
eribulin introduced after cdk4/6 inhibitors
Acesso em linha:https://ojrs.abvpress.ru/ojrs/article/view/864
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados